SLC9A1 and prostate cancer: Furthermore, ILK regulated both β1-integrin- and NHE1-driven invadopodial ECM proteolysis and cell invasion, thus promoting an invasive phenotype in breast and prostate cancer cells in vitro by coordinating an ECM proteolytic/invasion signal module.